R1 RCM (RCM) Prices 15M Share Secondary Offering at $22.50/Sh by Selling Shareholders

R1 RCM Inc. (NASDAQ: RCM) announced that it has priced the underwritten offering of 15,000,000 shares of its common stock by selling stockholders at a price to the public of $22.50 per share. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company. The underwriters will have a 30-day option to purchase up to an additional 2,250,000 shares of common stock from TCP-ASC. The offering is expected to close on June 1, 2021, subject to the satisfaction or waiver of customary closing conditions. R1 RCM is not selling any shares in the offering and will not receive any of the proceeds from the sale of common stock by the selling stockholders.

Barclays, J.P. Morgan, Morgan Stanley, BofA Securities and Deutsche Bank Securities are serving as active bookrunners for this offering.

You May Also Be Interested In

• Definium Therapeutics plans $500M public share offering
• PagerDuty names Eric Prengel as CFO as Howard Wilson retires
• Ambiq launches public offering of 1.8 million shares